Andrew Storey brings 40 years of senior leadership experience in the pharmaceutical and healthcare sector. He has held executive roles overseeing Regulatory Affairs, Quality Assurance and Clinical Research across both small and large organizations, guiding global mandates and leading large multinational teams. Throughout his career, he has played a key role in advancing biosimilar biologics, developing Countermeasures for Bioterrorism, and supporting the creation of novel orphan drugs and indications. During his time at AbbVie, he provided regulatory leadership for Humira, RinVoq, and Skyrizi along with more than 100 additional products.

Andrew holds a B.Sc. and a certificate in Quality Assurance from the University of Manitoba, a diploma in Chemical Technology from the New Brunswick Community College and a certificate in Executive Leadership from the Richard Ivey School of Business at Western University. He is now Senior Strategic Advisor to SNI, providing strategic guidance on complex regulatory, quality, and clinical development matters.